Robin Carhart-Harris

Psychedelics: Mind-Enhancing Methods to Well-Being

Tim Ferriss, Christian Angermayer, Robin Carhart-Harris, Matthew Johnson, Ayelet Waldman

In 1957, Katherine McCormick's pivotal funding enabled Gregory Pincus to develop the oral contraceptive, establishing a historical precedent for high-conviction scientific bets that now mirrors the current push to reclassify psychedelics like psilocybin and MDMA from Schedule I to Schedule IV. Recent clinical trials demonstrate these substances' efficacy in treating treatment-resistant depression, anxiety in cancer patients, and addiction, with effects often lasting months after a single session compared to the temporary relief provided by conventional SSRIs. Supported by major funding from investors like Christian Angermeyer and research from institutions such as Johns Hopkins and Imperial College London, the movement aims to integrate these therapies into a regulated medical model to address the growing global mental health crisis.